Search research articles
Contact Us
Filters
Showing results (1-10 of 196) with videos related to
Page
of 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 19, 2021
Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First
Thomas P Lodise, George Drusano
Journal of Hospital Medicine
|
January 13, 2011
Use of pharmacodynamic principles to inform β-lactam dosing: "S" does not always mean success
Thomas P Lodise, Jill Butterfield
International Journal of Chronic Obstructive Pulmonary Disease
|
May 19, 2021
Response to the Letter to the Editor Regarding "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Response to Letter]
Thomas P Lodise, Sanjay Sethi
Pharmacotherapy
|
April 9, 2020
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need
Thomas P Lodise, Michael J Rybak
Diagnostic Microbiology and Infectious Disease
|
June 21, 2005
Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
Thomas P Lodise, Peggy S McKinnon
Journal of Clinical Pharmacology
|
July 20, 2018
The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in Therapy
Evan J Zasowski, Thomas P Lodise
Pharmacotherapy
|
June 28, 2007
Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes
Thomas P Lodise, Peggy S McKinnon
Drugs
|
July 12, 2012
Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
Thomas P Lodise, Donald E Low
Pharmacotherapy
|
September 24, 2021
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline
Monique R Bidell, Thomas P Lodise
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary
Manjunath P Pai, Thomas P Lodise
Page
of 20
Search research articles
Search
Showing results (1-10 of 196) with videos related to
Sort By:
Page
of 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 19, 2021
Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First
Thomas P Lodise, George Drusano
Journal of Hospital Medicine
|
January 13, 2011
Use of pharmacodynamic principles to inform β-lactam dosing: "S" does not always mean success
Thomas P Lodise, Jill Butterfield
International Journal of Chronic Obstructive Pulmonary Disease
|
May 19, 2021
Response to the Letter to the Editor Regarding "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Response to Letter]
Thomas P Lodise, Sanjay Sethi
Pharmacotherapy
|
April 9, 2020
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need
Thomas P Lodise, Michael J Rybak
Diagnostic Microbiology and Infectious Disease
|
June 21, 2005
Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
Thomas P Lodise, Peggy S McKinnon
Journal of Clinical Pharmacology
|
July 20, 2018
The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in Therapy
Evan J Zasowski, Thomas P Lodise
Pharmacotherapy
|
June 28, 2007
Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes
Thomas P Lodise, Peggy S McKinnon
Drugs
|
July 12, 2012
Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
Thomas P Lodise, Donald E Low
Pharmacotherapy
|
September 24, 2021
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline
Monique R Bidell, Thomas P Lodise
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary
Manjunath P Pai, Thomas P Lodise
Page
of 20